Preferred Label : gadobenic acid, dimeglumine salt;
UMLS semantic type : T109 - Organic Chemical; T130 - Indicator, Reagent, or Diagnostic Aid;
CAS number : 127000-20-8; 3Q6PPC19PO;
Is substance : O;
UNII : 3Q6PPC19PO;
InChIKey : OCDAWJYGVOLXGZ-VPVMAENOSA-K;
Origin ID : M0324761;
UMLS CUI : C0209453;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
Exact mapping(s) to DCI
Related record
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/portail/jcms/c_2869904/fr/multihance
2018
false
false
false
France
French
evaluation of the transparency committee
child
adolescent
gadobenic acid, dimeglumine salt
gadobenic acid
organometallic compounds
meglumine
---
http://www.has-sante.fr/portail/jcms/c_1779498/fr/multihance
2014
false
France
French
breast neoplasms
gadobenic acid
meglumine
contrast media
organometallic compounds
treatment outcome
pharmaceutical solutions
injections, intravenous
gadobenic acid
evaluation of the transparency committee
gadobenic acid, dimeglumine salt
magnetic resonance imaging
adult
insurance, health, reimbursement
Outcome Assessment, Health Care
breast neoplasms
---
http://www.has-sante.fr/portail/jcms/c_834663/multihance-gadobenate-de-dimeglumine-produit-de-contraste
http://www.has-sante.fr/portail/jcms/c_1234480/multihance
http://www.has-sante.fr/portail/jcms/c_810805/multihance
http://www.has-sante.fr/portail/jcms/c_538092/multihance
http://www.has-sante.fr/portail/jcms/c_399155/multihance-0-5-mmol/ml-solution-injectable-iv-flacons-de-5-ml-10-ml-15-ml-et-20-ml
http://www.has-sante.fr/portail/jcms/c_1648993/fr/multihance
http://www.has-sante.fr/portail/jcms/c_1648992/fr/multihance-18092013-avis-ct12719
2013
France
French
magnetic resonance angiography
gadobenic acid
meglumine
contrast media
organometallic compounds
treatment outcome
pharmaceutical solutions
injections, intravenous
gadobenic acid
evaluation of the transparency committee
gadobenic acid, dimeglumine salt
magnetic resonance imaging
adult
child
central nervous system diseases
liver neoplasms
vascular diseases
insurance, health, reimbursement
Outcome Assessment, Health Care
vascular diseases
central nervous system diseases
liver neoplasms
---